Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,265 public trials 1,195 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study

NCT03634241

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

The Effect of Pulmonary Rehabilitation on Pulmonary Function Tests, Exercise Capacity, and Quality of Life in Patients With Advanced-Stage Lung Cancer Receiving Chemotherapy

NCT07532057

Conditions: Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +9 more
Locations: Istanbul Medipol University Istanbul, Kavacik, Turkey (Türkiye)

View Trial Details

Completed

A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

NCT01630733

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: University Cancer Institute Boynton Beach, Florida, United States

Florida Hospital Orlando, Florida, United States

University Cancer and Blood Center, LLC Athens, Georgia, United States

Joliet Oncology-Hematology Associates Ltd. Joliet, Illinois, United States

View all 78 locations

View Trial Details

Completed

Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer

NCT01118676

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: CHU Toulouse Larrey Toulouse, France

Institut Claudius Regaud Toulouse, France

View Trial Details

Completed

Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736)

NCT03446547

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Helsinki Helsinki, Finland

Dept of Oncology Tampere, Finland

Turku Turku, Finland

Dept of Oncology Vaasa, Finland

View all 15 locations

View Trial Details

Completed

Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland

NCT07526961

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Wielkopolska Center of Pulmonology and Thoracic Surgery of Eugenia and Janusz Zeyland Poznan, Poland

View Trial Details

Completed

Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

NCT05826366

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Research Site Aichi, Japan

Research Site Chiba, Japan

Research Site Fukuoka, Japan

Research Site Fukushima, Japan

View all 28 locations

View Trial Details

Completed

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

NCT05461430

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +139 more
Locations: xCures Oakland, California, United States

View Trial Details

Completed

Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer

NCT05106374

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial

NCT03523702

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Montefiore Medical Center The Bronx, New York, United States

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions